The regional cancer centre for Bristol and the south west of England, run by University Hospitals Bristol and Weston.
The Bristol Haematology and Oncology Centre is the specialist non-surgical cancer centre of University Hospitals Bristol and Weston NHS Foundation Trust, providing radiotherapy, chemotherapy, immunotherapy, haematology and stem cell transplantation, and teenage and young adult cancer services for Bristol, Bath, Somerset, Gloucestershire and parts of Wiltshire. It works with the University of Bristol on cancer epidemiology (Bristol is home to the Avon Longitudinal Study and Integrative Cancer Epidemiology Programme), and hosts clinical trials in haematology, lung and urological cancers.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-11.
Matched to University Hospitals Bristol and Weston NHS Foundation Trust (high confidence name match), including child institutions. 85 works · 1,339 citations · 87% open access · 8% clinical trials · 1% reviews.
The Bristol social scientist who worked out how to recruit men into a trial that asked them to accept a coin toss between surgery, radiotherapy and doing nothing, and then measured honestly what each did to their lives.
NHS leader who has been joint chief executive of University Hospitals Bristol and Weston and North Bristol since July 2024, the trusts that run the Bristol Haematology and Oncology Centre.
Shares EUROPAC, UK specialist HPB cancer centres, Clinical trial, Pancreatic ductal adenocarcinoma and the tag nhs-cancer-centre.
Shares Radiotherapy, Clinical trial and the tag nhs-cancer-centre.
Shares UK specialist HPB cancer centres, Pancreatic ductal adenocarcinoma and the tag nhs-cancer-centre.
Shares UK specialist HPB cancer centres, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag nhs-cancer-centre.
Shares Jenny Donovan, ProtecT, Prostate cancer.
Shares EUROPAC, UK specialist HPB cancer centres, Pancreatic ductal adenocarcinoma.
Shares EUROPAC, UK specialist HPB cancer centres, Pancreatic ductal adenocarcinoma.
Shares EUROPAC, UK specialist HPB cancer centres, Pancreatic ductal adenocarcinoma.